Research progress of CTHRC1 in gastrointestinal cancers

Abstract

Wang Yan, Wang Lu, Feng Jiangzhou, Li Deng. Research progress of CTHRC1 in gastrointestinal cancers[J]. Journal of International Oncology, 2016, 43(5): 382-384.

［1］ Jemal A, Center MM, Desantis C, et al. Global patterns of cancer incidence and mortality rates and trends［J］. Cancer Epidemiol Biomarkers Prev, 2010, 19(8): 1893-1907. DOI: 10.1158/10559965.EPI100437. ［2］ Pyagay P, Heroult M, Wang QZ, et al. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration［J］. Circ Res, 2005, 96(2): 261-268. DOI: 10.1161/01.RES.0000154262.07264.12. ［3］ Leclair R, Lindner V. The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling［J］. Trends Cardiovasc Med, 2007, 17(6): 202-205. DOI: 10.1016/j.tcm.2007.05.004. ［4］ Palma M, Lopez I, Garcia M, et al. Detection of collagen triple helix repeat containing 1 and nuclear factor (erythroidderived 2)like 3 in colorectal cancer［J］. BMC Clin Pathol, 2012, 12: 2. ［5］ Tang L, Dai DL, Su M, et al. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers［J］. Clin Cancer Res, 2006, 12(12): 3716-3722. ［6］ Yamamoto S, Nishimura O, Misaki K, et al. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wntreceptor complex［J］. Dev Cell, 2008, 15(1): 23-36. DOI: 10.1016/j.devcel.2008.05.007. ［7］黎联, 李敏, 周向东. ERK信号通路与MMP9在肺腺癌表达中的相关性［J］. 重庆医学, 2010, 39(17): 2256-2257, 2261. DOI: 10.3969/j.issn.16718348.2010.17.007. ［8］ Kim JH, Baek TH, Yim HS, et al. Collagen triple helix repeat containing1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features［J］. Pathol Oncol Res, 2013, 19(4): 731-737. DOI: 10.1007/s122530139636y. ［9］刘伟. 食管鳞癌发生过程中基因表达谱变化初步分析［D］. 南京: 南京医科大学, 2009. ［10］ Orloff M, Peterson C, He X, et al. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma［J］. JAMA, 2011, 306(4): 410-419. DOI: 10.1001/jama.2011.1029. ［11］刘伟, 施瑞华, 朱宏, 等. ITGA6、CTHRC1在食管鳞癌中的表达及临床意义［J］. 南京医科大学学报: 自然科学版, 2009， 29 (4): 508-511. ［12］ Wang P, Wang YC, Chen XY, et al. CTHRC1 is upregulated by promoter demethylation and transforming growth factorβ1 and may be associated with metastasis in human gastric cancer［J］. Cancer Sci, 2012, 103(7): 1327-1333. DOI: 10.1111/j.13497006.2012.02292.x. ［13］ Gu LA, Liu L, Zhong LL, et al. Cthrc1 overexpression is an independent prognostic marker in gastric cancer［J］. Hum Pathol, 2014, 45(5): 1031-1038. DOI: 10.1016/j.humpath.2013.12.020. ［14］万晓桢, 覃文新, 谭宁, 等. CTHRC1基因在人肝癌中高表达并促进MHCC97L肝癌细胞的转移［J］. 肿瘤, 2007, 27(6): 476-479, 483. DOI: 10.3781/j.issn.10007431.2007.06.015. ［15］ Yamamoto N, Shiraki K, Sugimoto KA, et al. Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility［J］. Int J Mol Med, 2014, 34(1): S30. ［16］ Chen YL, Wang TH, Hsu HC, et al. Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis［J］. PLoS One, 2013, 8(7): e70324. DOI: 10.1371/journal.pone.0070324. ［17］严力, 叶耿泰, 沈智勇, 等. CTHRC1在结直肠癌中的表达及作用机制［J］. 南方医科大学学报, 2015, 35(5): 767-771, 776. DOI: 10.3969/j.issn.16734254.2015.05.29. ［18］ Tan F, Liu F, Liu H, et al. CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis［J］. Med Oncol, 2013, 30(1): 473. DOI: 10.1007/s1203201304733. ［19］ Park EH, Kim S, Jo JY, et al. Collagen triple helix repeat containing1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells［J］. Carcinogenesis, 2013, 34(3): 694-702. DOI: 10.1093/carcin/bgs378. ［20］ Ma MZ, Zhuang C, Yang XM, et al. CTHRC1 Acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt/PCPRho signaling［J］. Neoplasia, 2014, 16(3): 265-278. DOI: 10.1016/j.neo.2014.03.001.

[1]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[2]	Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie.Research progress of myeloid-derived suppressor cells in tumor angiogenesis[J]. Journal of International Oncology, 2024, 51(1): 50-54.
[3]	Ye Tongtong, Wu Zeyu, Xi Wenyi, Wang Zhiwei, Jiang Xiaochun, Zhao Chenhui.Role of ABRACL in the occurrence and development of malignant tumors[J]. Journal of International Oncology, 2023, 50(9): 544-547.
[4]	Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462.
[5]	Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei.Current status of research on exosomes in malignancies[J]. Journal of International Oncology, 2023, 50(8): 484-488.
[6]	Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722.
[7]	Deng Lili, Duan Xingyu, Li Baozhong.Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma[J]. Journal of International Oncology, 2023, 50(12): 751-757.
[8]	Li Lixi, Wen Tingyu, Guan Xiuwen, Zhai Jingtong, Ma Fei.Genetic susceptibility genes and clinical features of early-onset breast cancer[J]. Journal of International Oncology, 2022, 49(4): 206-209.
[9]	Xu Kai, Wen Gang, Li Rui, Tian Yuan.Research progress on the prognostic value of the ratio of lymphocytes to C-reactive protein in digestive system neoplasms[J]. Journal of International Oncology, 2022, 49(10): 627-629.
[10]	Ju Xinyue, Hu Chunmei, Zhao Yue, Tang Yan.CDX2 and gastrointestinal neoplasms[J]. Journal of International Oncology, 2021, 48(6): 374-376.
[11]	Yu Jiaojiao, Wang Jun, Wang Likang, Yao Nan.Advances in the amplification of HER2 in metastatic colorectal cancer[J]. Journal of International Oncology, 2021, 48(4): 246-249.
[12]	Zheng Jing, Yao Sheng, Shen Wenjie, Sun Zhijia, Zhao Hui, Fu Yan, Gao Ke, Du Nan.Clinical study of intraperitoneal infusion of bevacizumab combined with albumin paclitaxel and carboplatin in carcinomatous peritoneal adhesion from ovarian cancer[J]. Journal of International Oncology, 2021, 48(11): 660-665.
[13]	Liu Peipei, Yang Mengxue, Yan Xuebing.Research advances of m⁶A methylation modification in digestive system neoplasms[J]. Journal of International Oncology, 2021, 48(11): 688-692.
[14]	Ren Meng, Gao Yan, Chen Qi, Yue Wentao.Application of keratins in cancer diagnosis and prognosis[J]. Journal of International Oncology, 2020, 47(6): 360-363.
[15]	Ma Yingji, Sun Libin, Qiu Wensheng.Mechanism of long non-coding RNA GHET1 in tumors of the digestive system[J]. Journal of International Oncology, 2020, 47(5): 304-307.

Research progress of CTHRC1 in gastrointestinal cancers

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments